30.67
price up icon4.57%   1.34
after-market 시간 외 거래: 30.41 -0.26 -0.85%
loading
전일 마감가:
$29.33
열려 있는:
$29.77
하루 거래량:
5.64M
Relative Volume:
4.10
시가총액:
$19.68B
수익:
$2.62B
순이익/손실:
$966.70M
주가수익비율:
20.44
EPS:
1.5004
순현금흐름:
$1.09B
1주 성능:
+6.75%
1개월 성능:
+23.32%
6개월 성능:
+56.64%
1년 성능:
+25.80%
1일 변동 폭
Value
$29.77
$30.84
1주일 범위
Value
$28.36
$30.84
52주 변동 폭
Value
$17.23
$30.84

Genmab Adr Stock (GMAB) Company Profile

Name
명칭
Genmab Adr
Name
전화
-
Name
주소
-
Name
직원
2,639
Name
트위터
@Genmab
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
GMAB's Discussions on Twitter

GMAB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GMAB
Genmab Adr
30.67 18.05B 2.62B 966.70M 1.09B 1.5004
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Genmab Adr Stock (GMAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-23 업그레이드 Guggenheim Neutral → Buy
2025-04-01 다운그레이드 Bernstein Mkt Perform → Underperform
2025-03-11 업그레이드 William Blair Mkt Perform → Outperform
2025-02-13 업그레이드 Leerink Partners Market Perform → Outperform
2024-10-08 개시 Redburn Atlantic Buy
2024-09-04 재개 Morgan Stanley Equal-Weight
2024-08-20 다운그레이드 JP Morgan Overweight → Neutral
2024-07-15 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2024-02-23 업그레이드 BMO Capital Markets Market Perform → Outperform
2024-01-22 다운그레이드 Citigroup Neutral → Sell
2023-12-06 업그레이드 UBS Neutral → Buy
2023-11-10 업그레이드 Deutsche Bank Hold → Buy
2023-11-08 업그레이드 DNB Markets Sell → Buy
2023-10-18 개시 Exane BNP Paribas Underperform
2023-09-06 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-08-24 개시 BTIG Research Buy
2023-07-14 개시 HSBC Securities Buy
2023-05-31 개시 UBS Neutral
2023-05-12 개시 Morgan Stanley Underweight
2022-12-20 다운그레이드 Citigroup Buy → Neutral
2022-11-14 개시 William Blair Mkt Perform
2022-11-11 다운그레이드 Deutsche Bank Buy → Hold
2022-06-24 개시 BMO Capital Markets Market Perform
2022-05-02 개시 Cowen Market Perform
2022-03-16 업그레이드 UBS Neutral → Buy
2022-01-31 업그레이드 H.C. Wainwright Neutral → Buy
2022-01-03 다운그레이드 Guggenheim Buy → Neutral
2021-12-01 개시 Berenberg Sell
2021-09-16 다운그레이드 Jefferies Buy → Hold
2021-09-07 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2021-08-24 다운그레이드 H.C. Wainwright Buy → Neutral
2021-04-20 개시 Deutsche Bank Buy
2021-01-19 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-09-23 다운그레이드 Bryan Garnier Neutral → Sell
2020-09-08 개시 SVB Leerink Mkt Perform
2020-06-25 다운그레이드 Credit Suisse Outperform → Neutral
2020-04-23 개시 Credit Suisse Outperform
2020-02-24 재확인 H.C. Wainwright Buy
2020-01-13 개시 SunTrust Buy
2019-12-12 다운그레이드 Deutsche Bank Buy → Hold
2019-09-13 업그레이드 BofA/Merrill Neutral → Buy
2019-09-12 업그레이드 JP Morgan Neutral → Overweight
2019-08-12 개시 Guggenheim Buy
2019-08-12 개시 Morgan Stanley Overweight
2019-08-12 개시 RBC Capital Mkts Outperform
모두보기

Genmab Adr 주식(GMAB)의 최신 뉴스

pulisher
03:28 AM

Park Avenue Securities LLC Acquires 832 Shares of Genmab A/S Sponsored ADR $GMAB - Defense World

03:28 AM
pulisher
Sep 30, 2025

TD Private Client Wealth LLC Has $130,000 Stock Holdings in Genmab A/S Sponsored ADR $GMAB - Defense World

Sep 30, 2025
pulisher
Sep 30, 2025

Genmab A/S (NASDAQ:GMAB) Sees Strong Trading Volume on Analyst Upgrade - Defense World

Sep 30, 2025
pulisher
Sep 29, 2025

Genmab A/S (NASDAQ:GMAB) Sees Large Volume Increase After Analyst Upgrade - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Genmab Makes $8 Billion Bet On Merus With Potential Cancer Breakthrough - Benzinga

Sep 29, 2025
pulisher
Sep 29, 2025

European Stocks Higher to Kick Off the Week - TradingView

Sep 29, 2025
pulisher
Sep 29, 2025

Genmab A/S Sponsored ADR $GMAB Shares Sold by Fifth Third Bancorp - Defense World

Sep 29, 2025
pulisher
Sep 29, 2025

Before the bell: futures up, Lufthansa cuts jobs, GSK CEO steps down - TradingView

Sep 29, 2025
pulisher
Sep 29, 2025

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model - Placera.se

Sep 29, 2025
pulisher
Sep 25, 2025

Genmab A/S (NASDAQ:GMAB) Upgraded by Guggenheim to Buy Rating - Defense World

Sep 25, 2025
pulisher
Sep 25, 2025

Genmab A/S Sponsored ADR $GMAB Shares Purchased by Parallel Advisors LLC - Defense World

Sep 25, 2025
pulisher
Sep 25, 2025

Rhumbline Advisers Increases Stock Holdings in Genmab A/S Sponsored ADR $GMAB - Defense World

Sep 25, 2025
pulisher
Sep 24, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Genmab A/S (NASDAQ:GMAB) Hits New 12-Month High Following Analyst Upgrade - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

Genmab A/S (NASDAQ:GMAB) Sets New 52-Week High Following Analyst Upgrade - MarketBeat

Sep 23, 2025
pulisher
Sep 16, 2025

Foresight Group Ltd Liability Partnership Takes Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Vident Advisory LLC Buys Shares of 12,377 Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 16, 2025
pulisher
Sep 15, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Sep 15, 2025
pulisher
Sep 15, 2025

Scientech Research LLC Increases Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Genmab A/S (NASDAQ:GMAB) Sets New 1-Year HighStill a Buy? - MarketBeat

Sep 14, 2025
pulisher
Sep 10, 2025

Northern Trust Corp Raises Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Genmab A/S Sponsored ADR $GMAB Shares Sold by Alliancebernstein L.P. - MarketBeat

Sep 09, 2025
pulisher
Sep 08, 2025

Graham Capital Management L.P. Acquires 16,035 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 08, 2025
pulisher
Sep 05, 2025

Cubist Systematic Strategies LLC Grows Holdings in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 05, 2025
pulisher
Sep 04, 2025

Orbis Allan Gray Ltd Has $111.82 Million Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 04, 2025
pulisher
Sep 03, 2025

Synovus Financial Corp Takes $633,000 Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 03, 2025
pulisher
Sep 02, 2025

Tema Etfs LLC Boosts Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 02, 2025
pulisher
Sep 01, 2025

Cresset Asset Management LLC Has $244,000 Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat

Sep 01, 2025
pulisher
Aug 27, 2025

Cresset Asset Management LLC Has $244,000 Stock Position in Genmab A/S Sponsored ADR $GMAB - Defense World

Aug 27, 2025
pulisher
Aug 27, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Aug 27, 2025
pulisher
Aug 22, 2025

Genmab A/S (NASDAQ:GMAB) Cut to Hold at Zacks Research - Defense World

Aug 22, 2025
pulisher
Aug 21, 2025

IBD Rating Upgrades: MINISO Group Holding ADR Flashes Improved Technical Strength - inkl

Aug 21, 2025
pulisher
Aug 20, 2025

IBD Rating Upgrades: Genmab ADR Shows Improved Relative Price Strength - Investor's Business Daily

Aug 20, 2025
pulisher
Aug 19, 2025

Biotech Stocks To Watch And Pharma Industry News - Investor's Business Daily

Aug 19, 2025
pulisher
Aug 19, 2025

IBD Rating Upgrades: Applied Indl Techs Shows Improved Relative Price Strength - inkl

Aug 19, 2025
pulisher
Aug 18, 2025

What is HC Wainwright’s Forecast for Genmab A/S Q1 Earnings? - Defense World

Aug 18, 2025
pulisher
Aug 18, 2025

IBD Rating Upgrades: HCA Healthcare Shows Improved Technical Strength - inkl

Aug 18, 2025
pulisher
Aug 15, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by LPL Financial LLC - Defense World

Aug 15, 2025
pulisher
Aug 11, 2025

What is William Blair’s Forecast for Genmab A/S Q3 Earnings? - Defense World

Aug 11, 2025
pulisher
Aug 09, 2025

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade - MSN

Aug 09, 2025
pulisher
Aug 08, 2025

Genmab and BioNTech’s Innovative Cancer Trial: A Market Game Changer? - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

BioNTech and Genmab’s Promising Colorectal Cancer Study: A Potential Game-Changer? - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

GMAB: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com

Aug 07, 2025

Genmab Adr (GMAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$84.81
price up icon 1.10%
$98.62
price up icon 0.53%
$20.66
price down icon 2.36%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
자본화:     |  볼륨(24시간):